CONFALONIERI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 1.215
EU - Europa 1.142
AS - Asia 840
AF - Africa 16
SA - Sud America 10
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.227
Nazione #
US - Stati Uniti d'America 1.200
IT - Italia 541
SG - Singapore 270
HK - Hong Kong 228
CN - Cina 214
SE - Svezia 179
DE - Germania 67
FI - Finlandia 62
BG - Bulgaria 55
IE - Irlanda 44
CH - Svizzera 37
GB - Regno Unito 33
IN - India 28
KR - Corea 28
VN - Vietnam 25
PL - Polonia 22
UA - Ucraina 18
NL - Olanda 16
FR - Francia 15
ES - Italia 11
BE - Belgio 10
SN - Senegal 10
CA - Canada 8
AT - Austria 7
JP - Giappone 7
TR - Turchia 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
MX - Messico 5
BR - Brasile 4
DK - Danimarca 4
EG - Egitto 4
IR - Iran 4
CL - Cile 3
CO - Colombia 3
IQ - Iraq 3
KZ - Kazakistan 3
RO - Romania 3
SA - Arabia Saudita 3
YE - Yemen 3
AU - Australia 2
ID - Indonesia 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PR - Porto Rico 1
Totale 3.227
Città #
Chandler 258
Hong Kong 221
Singapore 215
Trieste 119
Boardman 109
Columbus 81
Ashburn 75
Princeton 56
Sofia 55
Beijing 54
Santa Clara 53
Milan 41
Lappeenranta 35
Dublin 32
Redmond 29
Seoul 28
Helsinki 26
Wilmington 26
Bern 25
Dong Ket 25
Warsaw 22
Rome 17
Los Angeles 16
Bremen 14
Ann Arbor 12
Seattle 12
Turin 12
Woodbridge 12
Redwood City 11
Shanghai 11
Dakar 10
Tappahannock 10
Boydton 9
Brussels 9
Fairfield 9
Padova 9
Pune 9
Grafing 8
Jacksonville 8
Udine 8
Guangzhou 7
Manchester 7
Munich 7
Naples 7
Somerville 7
Treviso 7
Washington 7
Menomonie 6
San Donà di Piave 6
Verona 6
Birmingham 5
Bologna 5
Dallas 5
Duino-Aurisina 5
Saint Louis 5
Vienna 5
Amsterdam 4
Bari 4
Beregazzo con Figliaro 4
Calcinato 4
Central 4
Council Bluffs 4
Gurgaon 4
London 4
Moscow 4
Paris 4
Pescara 4
San Floriano del Collio 4
Tokyo 4
Tolmezzo 4
West Jordan 4
Ankara 3
Beauharnois 3
Capo d'Orlando 3
Cittadella 3
Gainesville 3
Genoa 3
Houston 3
Kochi 3
Liverpool 3
Madrid 3
Mantova 3
Mignagola 3
Mirano 3
Monte San Pietro 3
Najaf 3
Nanjing 3
Nashville 3
Perugia 3
Pordenone 3
Raleigh 3
S. Pietro 3
San Diego 3
San Francisco 3
Sassari 3
Shenzhen 3
Spilimbergo 3
Tainan City 3
Torino 3
Venezia 3
Totale 2.035
Nome #
Alveolar Epithelial Type II Cells 148
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 115
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 101
The Treatment of Lung Involvement in Systemic Sclerosis 100
Chronic Thromboembolic Pulmonary Hypertension: An Update 95
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 92
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 89
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 84
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 83
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 82
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 80
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 76
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 74
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 70
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 69
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 68
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 67
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 65
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 64
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 63
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 61
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 61
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 60
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 60
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 57
Caution When Comparing the Impact of Corticosteroids in COVID-19 57
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 56
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 56
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 55
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 55
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 52
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 52
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 51
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 50
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 48
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 44
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 44
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 42
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 42
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 40
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 39
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 39
Host-Based Treatments for Severe COVID-19 38
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 36
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 34
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 34
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 33
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 32
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 31
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 29
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 29
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 29
Biomarkers in Systemic Sclerosis: An Overview 28
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 27
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 27
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 27
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 26
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 24
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 24
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 22
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 20
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study 18
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 18
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 18
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 17
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 15
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis 11
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 11
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 10
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 10
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 7
Trattamenti dell’ipertensione polmonare tromboembolica cronica (CTEPH): uno studio pilota 6
Totale 3.497
Categoria #
all - tutte 17.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 2 33 20 17 15 29 23 40 8 12
2021/2022489 43 12 28 57 39 13 32 14 72 35 41 103
2022/2023942 79 112 94 90 78 117 29 85 119 24 75 40
2023/20241.074 70 48 81 74 108 92 223 134 39 47 96 62
2024/2025793 59 129 173 206 187 39 0 0 0 0 0 0
Totale 3.497